Loading results ...
 

Blog Posts

Pharmacogenomic Research as an Integral Component of Drug Development

The ability to conduct unbiased, genome-wide pharmacogenomic research has been greatly enhanced by the convergence of several factors. First, the cost of performing genome-wide genotyping on a Single Nucleotide Polymorphism Single (SNP) array is now about par with many other clinical assays routinely performed (~$100). Further, Whole Exome Sequencing (WES) now costs less than $1000 […]

Read more »

2015 EU Data Protection Regulation – Impact on Research Updates

Important decisions are soon to be made that will govern the use of personal data to support research studies in Europe. In 1995, the European Union passed an EU Data Protection Directive (EU 95/96) aimed at protecting the data privacy of EU residents by providing EU citizens with fundamental privacy rights such as the right […]

Read more »

Turning Data into Intelligence

Today’s organizations are built on data. Tons and tons of data. Taking that data and turning it into intelligence is one of the most common challenges in clinical research and drug development organizations. Data by itself doesn’t provide value to an organization. What do I mean by that? Data itself is just that: words and/or […]

Read more »

Growing importance of sample data integration to researchers

The need for high-quality samples and corresponding data by medical researchers is predicted to be increasing in importance at an exponential rate over the next few years. The leading research factors driving this demand are increasing investment in chronic diseases such as cancer, innovation in genomics and an increasing focus on regenerative medicine. Recently, the […]

Read more »

New Technologies Advancing Translational Research and Biomarker Development

In today’s era of personalized medicine, new advancements in biospecimen management, science and technology are enabling researchers to introduce innovative medical therapies to the market. Technology continues to be a key driver that is impacting how biological samples are being used to make more specific and sensitive measurements of molecular biomarkers. The discovery of biomarkers […]

Read more »

BioStorage Firmly Behind the Scenes of Personalized Medicine

Personalized medicine, the precise targeting of specific drugs to treat specific patients based on the genetic details of their disease, is quickly becoming a reality. In fact, the precipitous decline in the cost of sequencing patients’ specimens is leading to a flood of genetic information that is being exploited to diagnose and treat patients. An […]

Read more »

Top Trends in R&D Outsourcing Impacting Future R&D Success

The biopharmaceutical industry faces a unique challenge in its quest to develop new and innovative therapies. Unlike any other industry, Biopharma research is dependent upon the human body and its genome. In a sense, it is working to drive continual innovation within a highly complex, but closed environment. Not surprisingly, Biopharma is finding it more […]

Read more »

Is Your Biorepository a Certified Cargo Screening Facility?

Due to the substantial requirements of the 9/11 Act, pre-inspection of research samples at a Certified Cargo Screening Facility can eliminate bottlenecks in the air cargo supply chain and reduce the risk of transportation damage to precious cargo, saving you time and money. In July of 2010, BioStorage Technologies was approved as a Certified Cargo […]

Read more »

Join BioStorage Technologies at ISBER for Workshops, Poster Presentations, Interactive Discussions and a Fireworks Party!

The International Society for Biological and Environmental Repositories (ISBER) is a global biobanking community that supports the largest international forum for technical, legal, ethical and managerial issues relevant to repositories of biological and environmental specimens worldwide. The ISBER 2014 Annual Meeting takes place May 20-24 at Walt Disney World in Orlando, FL. This meeting will […]

Read more »

The Role of Technology in Advancing Pharmaceutical Drug Discovery and Development

Embracing Innovative Technologies The drug development industry is entering a new technology era that is filled with both opportunities and challenges. Due to an increasing array of cost-reduction, efficiency objectives and safety drivers from the commercial, regulatory and patient sectors –the likes of which have never been seen before – research organizations are embracing innovative […]

Read more »